Preferred Name | Icosapent Ethyl | |
Synonyms |
|
|
Definitions |
A highly purified omega-3 fatty acid that can decrease serum triglyceride levels. Icosapent ethyl reduces serum triglycerides without an increase in LDL cholesterol, but increases the cholesterol and triglyceride content in skeletal muscle. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C72986 |
|
Accepted_Therapeutic_Use_For |
Treatment of hypertriglyceridemia |
|
CAS_Registry |
73310-10-8 |
|
Chemical_Formula |
C22H34O2 |
|
code |
C72986 |
|
Contributing_Source |
CTRP FDA |
|
definition |
A highly purified omega-3 fatty acid that can decrease serum triglyceride levels. Icosapent ethyl reduces serum triglycerides without an increase in LDL cholesterol, but increases the cholesterol and triglyceride content in skeletal muscle. |
|
Display_Name |
Icosapent Ethyl |
|
FDA_UNII_Code |
6GC8A4PAYH |
|
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C173383 http://purl.obolibrary.org/obo/NCIT_C173381 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
label |
Icosapent Ethyl |
|
Legacy Concept Name |
Ethyl_Icosapentate |
|
NCI_Drug_Dictionary_ID |
785885 |
|
PDQ_Closed_Trial_Search_ID |
785885 |
|
PDQ_Open_Trial_Search_ID |
785885 |
|
Preferred_Name |
Icosapent Ethyl |
|
prefixIRI |
NCIT:C72986 |
|
prefLabel |
Icosapent Ethyl |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C3486026 |
|
subClassOf |